Search

Search Results

• THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

  Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini

  e2016025

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.025

  6356

  PDF: 2134

  HTML: 14026

  Untitled: 206

  figure: 189

• Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.

  John Ayodele Olaniyi

  e2011008

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.008

  2389

  PDF: 586

  HTML: 1170

• POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

  Daniela Capello, Gianluca Gaidano

  e2009018

  https://doi.org/10.4084/mjhid.2009.018

  1261

  PDF: 477

  HTML: 18611

  Figure 1: 174

  Figure 2: 154

  Figure 3: 171

  Figure 4: 210

  Figure 5: 182

• FLT3 INTERNAL TANDEM DUPLICATION AND D835 MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CLINICAL SIGNIFICANCE

  Ghaleb Elyamany, Mohamed Awad, Omar Alsuhaibani, Kamal Fadalla, Omer Al Sharif, Mohammad Al Shahrani, Fahad Alabbas, Abdulaziz Al-Abulaaly

  e2014038

  2014-05-30

  https://doi.org/10.4084/mjhid.2014.038

  1842

  PDF: 977

  HTML: 7172

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

  Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

  e2024061

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.061

  2844

  PDF: 3236

  HTML: 516

• Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

  Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

  e2017034

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.034

  2659

  PDF: 1043

  HTML: 1175

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2634

  PDF: 1627

  HTML: 2373

  Table1: 193

• DETECTION OF ? THALASSEMIA CARRIERS BY RED CELL PARAMETERS OBTAINED FROM AUTOMATIC COUNTERS USING MATHEMATICAL FORMULAS

  Idit Lachover Roth, Boaz Lachover, Guy Koren, Carina Levin, Luci Zalman, Ariel Koren

  e2018008

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.008

  4869

  PDF: 1725

  HTML: 1107

• COINCIDENCE OR CONNECTION? REVISITING THE RELATIONSHIP BETWEEN MASTOCYTOSIS AND LYMPHOMA

  Antonio Frolli, Cristina Papayannidis, Carmen Fava, Martina Bullo, Selene Grano, Valentina Bonuomo, Daniela Gottardi, Guido Parvis, Beatrice Casadei, Daniela Cilloni

  e2026047

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.047

  194

  PDF: 211

  HTML: 15

• REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

  Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst

  e2021012

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.012

  1601

  PDF: 621

  HTML: 209

• BONE MARROW ABONRMALITIES IN HIV INFECTION

  Sharad Antiram Dhurve

  e2013033

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.033

  1899

  PDF: 1144

  HTML: 1767

• Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia

  Monique A Hartley-Brown, Lubomir Sokol, Gisela L Caceres, Mohammed A Hussein, Alan List, Javier Pinilla-Ibarz

  e2010002

  2010-02-23

  https://doi.org/10.4084/mjhid.2010.002

  1044

  PDF: 553

  HTML: 403

• GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

  Francesco Fabozzi, Angela Mastronuzzi

  e2023032

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.032

  1967

  PDF: 518

  HTML: 587

• Coexisting Pulmonary Tuberculosis and Mucormycosis in a Patient with Aplastic Anemia Post Allogenic Stem Cell Transplantion

  Sanjeev Kumar Sharma, Narendra Agrawal, Anjan Mukherjee, Tulika Seth, Pravas Mishra, Immaculata Xess, Manoranjan Mahapatra, Sanjay Sharma

  e2011036

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.036

  1883

  PDF: 706

  HTML: 883

• Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients

  Romain Fort, Guillaume Monneret, Elie Nader, Giovanna Cannas, Philippe Connes, Fabienne Venet, Arnaud Hot

  e2022078

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.078

  710

  PDF: 549

  HTML: 219

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  3936

  PDF: 1490

  HTML: 8518

• CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

  Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori

  e2019048

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.048

  1967

  PDF: 1178

  HTML: 275

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3524

  PDF: 1608

  HTML: 7834

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2084

  PDF: 1902

  HTML: 350

• RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

  Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone

  e2023062

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.062

  1239

  PDF: 1079

  HTML: 206

• COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

  Surbhi Goyal, Usha Rani Singh, Usha Rusia

  e2014002

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.002

  1975

  PDF: 1069

  HTML: 51807

• CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

  Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti

  e2014075

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.075

  4129

  PDF: 1951

  HTML: 5325

  Table 1: 200

• BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement

  Dr. Leonid Livshits, Ms. Tal Bilu, Ms. Sari Peretz, Prof. Anna Bogdanova, Prof. Max Gassmann, Dr. Harel Eitam, Prof. Ariel Koren, Prof. Carina Levin

  e2022049

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.049

  2246

  PDF: 846

  HTML: 500

• INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

  Giuseppe Leone, Livio Pagano

  e2018039

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.039

  4218

  PDF: 1460

  HTML: 609

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1562

  PDF: 1379

  HTML: 116

• Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease

  Giacomo Andreani, Gianluca Fadda, Dario Gned, Matteo Dragani, Giovanni Cavallo, Valentina Monticone, Alessandro Morotti, Marco De Gobbi, Angelo Guerrasio, Antonio D'Avolio, Daniela Cilloni

  e2019061

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.061

  1434

  PDF: 1094

  HTML: 198

• SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

  Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso

  e2011052

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.052

  3652

  PDF: 900

  HTML: 6721

• Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

  Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello

  e2025043

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.043

  1195

  PDF: 968

  HTML: 153

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3676

  PDF: 941

  HTML: 4468

• MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

  Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh

  e2025032

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.032

  847

  PDF: 867

  HTML: 127

• Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

  Edoardo Olivari

  e2025040

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.040

  1060

  PDF: 779

  HTML: 156

• PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

  Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus

  e2014053

  2014-07-04

  https://doi.org/10.4084/mjhid.2014.053

  3368

  PDF: 1977

  HTML: 7479

• INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

  V. De Sanctis

  e2014.074

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.074

  2268

  PDF: 950

  HTML: 26949

• INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

  Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni

  e2016006

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.006

  4463

  PDF: 1337

  HTML: 2159

• CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

  Edoardo Olivari

  e2025079

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.079

  458

  PDF: 211

  Html: 65

• WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

  Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi

  e2018004

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.004

  7654

  PDF: 2437

  HTML: 1740

  Table 1.: 214

  Table 2.: 224

  Table 3.: 208

  Table 4.: 208

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  1965

  PDF: 1662

  HTML: 133

• STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .

  Seham Ragab, Manal A. Safan, Eman A. Badr

  e2015019

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.019

  2219

  PDF: 1175

  HTML: 2594

  Study of serum haptoglobin level in thalassemia: 350

  Figures: 183

• IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES

  Paolo Cianciulli

  e2009034

  1276

  PDF: 618

  HTML: 2321

• OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

  Mohamed Amine BEKADJA

  e2017062

  2017-10-25

  https://doi.org/10.4084/mjhid.2017.062

  2875

  PDF: 737

  HTML: 912

• IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

  Tomasz Sacha

  e2014007

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.007

  4810

  PDF: 2858

  HTML: 2307

• SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

  Firas Kreidieh, Sally Temraz

  e2020078

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.078

  1088

  PDF: 967

  HTML: 337

• COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

  M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher

  e2009029

  2009-12-28

  1127

  PDF: 488

  HTML: 8182

• Bacteraemia Among Patients with Sickle Cell Disease in Nigeria: Association with Spleen Size and Function

  adama isah ladu, Mairo Usman Kadaura, Mohammed Dauda, Abubakar Sadiq Baba, Caroline Jeffery, Abubakar Farate, Adekunle Adekile, Imelda Bates, Russell Dacombe

  e2023054

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.054

  803

  PDF: 521

  HTML: 131

• DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

  Ali Taher

  e2018066

  2018-11-01

  https://doi.org/10.4084/mjhid.2018.066

  2949

  PDF: 1599

  HTML: 239

• THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

  George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe

  e2020011

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.011

  2431

  PDF: 1597

  HTML: 644

• ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY

  Deniz Guven, Dr. İncefidan, Dr. Kazanci, Dr. Ozlem Kara

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.017

  668

  PDF: 558

  HTML: 72

• SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.

  Ilhami Berber, Ozlem Cagasar, Ahmet Sarıcı, Nurcan Kirici Berber, Ismet Aydogdu, Asli Yildirim, Harika Gozde Gocukara Bag, Leman Acun Delen, Ozkan Ulutas

  e2021009

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.009

  3342

  PDF: 1145

  HTML: 448

• Madurella mycetomatis infection following allogenic stem cell transplantation for aplastic anemia

  Sanjeev Kumar Sharma, Anjan Mukherjee, Avinash Kumar Singh, Tuika Seth, Suman Kumar, Pravas Mishra, Immaculata Xess, Somesh Gupta, Manoranjan Mahapatra, Haraprasad Pati

  e2012038

  2012-06-13

  https://doi.org/10.4084/mjhid.2012.038

  1499

  PDF: 807

  HTML: 8977

• DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS

  HADI YASSINE

  e2022076

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.076

  1373

  PDF: 1015

  HTML: 343

  Suppl. Figure: 184

  Suppl. Tables: 207